Literature DB >> 10875526

Effect of vitamin D and calcium on bone mineral density in children with CP and epilepsy in full-time care.

M Jekovec-Vrhovsek1, A Kocijancic, J Prezelj.   

Abstract

Atraumatic fractures are often seen in children and adolescents with cerebral palsy (CP) and epilepsy in full-time care. Increased bone fragility was postulated to be due to osteopenia resulting from a combination of factors including immobilization and antiepileptic treatment. The aim of this study was to determine the effect of vitamin D and calcium substitution on bone mineral density (BMD) in a group of children with CP in full-time care. Twenty children with the most severe form of CP (spastic quadriplegia) who had been treated with antiepileptic drugs for a relatively long period of time were included in the study. Physical examination and laboratory analyses excluded other possible causes of osteopenia. BMD was measured by dual X-ray absorptiometry. Thirteen patients were treated for 9 months with 1,25-dihydroxy-cholecalciferol vitamin D (0.25 mcg daily) and with calcium (500 mg daily). Seven control children were used for observation only. BMD greatly increased in the treated group, while children with CP in full-time care who did not receive vitamin D and calcium substitution continued to lose their bone mass. It can be concluded that the addition of vitamin D and calcium increases BMD in children with the most severe form of CP, who are receiving antiepileptic drugs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10875526

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  13 in total

Review 1.  Osteoporosis in children and adolescents: etiology and management.

Authors:  Giampiero Igli Baroncelli; Silvano Bertelloni; Federica Sodini; Giuseppe Saggese
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

2.  Effect of supplementation with cholecalciferol and calcium on 2-y bone mass accrual in HIV-infected children and adolescents: a randomized clinical trial.

Authors:  Stephen M Arpadi; Donald J McMahon; Elaine J Abrams; Mahrukh Bamji; Murli Purswani; Ellen S Engelson; Mary Horlick; Elizabeth Shane
Journal:  Am J Clin Nutr       Date:  2012-01-18       Impact factor: 7.045

3.  Bone mineral density and insulin-like growth factor-1 in children with spastic cerebral palsy.

Authors:  H Nazif; R Shatla; R Elsayed; E Tawfik; N Osman; S Korra; A Ibrahim
Journal:  Childs Nerv Syst       Date:  2017-02-24       Impact factor: 1.475

Review 4.  Fractures in children with cerebral palsy.

Authors:  M Zulf Mughal
Journal:  Curr Osteoporos Rep       Date:  2014-09       Impact factor: 5.096

Review 5.  Bone density in cerebral palsy.

Authors:  Christine Murray Houlihan; Richard D Stevenson
Journal:  Phys Med Rehabil Clin N Am       Date:  2009-08       Impact factor: 1.784

6.  Epidemiology of fractures in people with severe and profound developmental disabilities.

Authors:  Norris R Glick; Milton H Fischer; Dennis M Heisey; Glen E Leverson; David C Mann
Journal:  Osteoporos Int       Date:  2004-08-07       Impact factor: 4.507

7.  Multiple Nutritional Deficiencies in Cerebral Palsy Compounding Physical and Functional Impairments.

Authors:  P G Hariprasad; K E Elizabeth; Mathew J Valamparampil; D Kalpana; T S Anish
Journal:  Indian J Palliat Care       Date:  2017 Oct-Dec

8.  Association of 25-Hydroxyvitamin D Deficiency in Pediatric Epileptic Patients.

Authors:  Jaydip Ray Chaudhuri; Kandadai Rukmini Mridula; Chakrala Rathnakishore; Banda Balaraju; Vcs Srinivasarao Bandaru
Journal:  Iran J Child Neurol       Date:  2017

9.  The impact of vitamin D supplementation on musculoskeletal health outcomes in children, adolescents, and young adults living with HIV: A systematic review.

Authors:  Justin Penner; Rashida A Ferrand; Ceri Richards; Kate A Ward; James E Burns; Celia L Gregson
Journal:  PLoS One       Date:  2018-11-15       Impact factor: 3.240

10.  Vitamin D deficiency in children with epilepsy: Do we need to detect and treat it?

Authors:  Pooja Harijan; Arif Khan; Nahin Hussain
Journal:  J Pediatr Neurosci       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.